Welcome to HealthcareBanker.com

Thank you for visiting HealthcareBanker.com a news aggregator of middle-market mergers and acquisition activity in the healthcare industries. This site addresses investment banking topics dealing with M&A, Capital Raising, Borrowing/Lending and other Corporate Development and Finance activities within the Healthcare Services, Healthcare IT, Medical Device, and Life Science industries.

Friday, January 25, 2019

2019 JPM Healthcare Conference Recap – Deals, ACA, Outlook, & More!


(By David Lopez)

The 37th Annual J.P. Morgan Healthcare Conference kicked-off on Jan. 7 with a bang as Eli Lilly and Company (LLY) announced that it would acquire Loxo Oncology (LOXO) for $8 billion. Loxo Oncology will provide Eli Lilly with access to several cutting-edge cancer fighting drugs including those that inhibit oncogenic drivers in cancer. Eli Lilly purchased Loxo at a premium of about 68% or $235-per-share. 

The deal is the second largest biotech acquisition since the start of the new year. The first being Bristol Myers Squibb Co’s (BMY) acquisition of Celgene Corp. (CELG) for $74 billion, which was announced on Jan. 3.

Thursday, December 13, 2018

High Valuations Not Detering M&A In Healthcare IT


Healthcare IT Investment is Overvalued, But Will Increase Next Year

(from HealthLeaders)

While most healthcare industry players believe healthcare IT is an overvalued subsector, they still expect investment to rise in 2019, according to the KPMG-Leavitt Partners 2019 Investment Outlook survey.

More than 60% of healthcare professionals view healthcare IT asset prices as overvalued but also expect the subsector to grow faster than the overall healthcare market, according to a new survey released by KPMG-Leavitt Partners Monday morning.

Wednesday, November 21, 2018

Healthcare M&A Requires More Sophistication From Private Equity

       
Building a Successful Health Care Portfolio

Health care investments require specialized treatment



The booming health care market offers lucrative investment opportunities. In 2017, private equity investment in the U.S. health care market totaled $83 billion, up from $72 billion in 2016, according to the American Investment Council. And the surge is continuing. The first few months of 2018 saw the busiest start to a year in health care mergers and acquisitions in more than a decade, with approximately $156 billion worth of M&A deals (of all types, not just private equity) already agreed upon, the strongest start in over a decade, according to Bloomberg Markets.

Thursday, October 25, 2018

Communication During A Healthcare M&A Transaction: Why It's So Important To Have A Strategy


M&A Management 101: Communicate Constantly for Successful Due Diligence from Start to New Beginning

(from Radiology Business)

The pace of merger and acquisition (M&A) activity in healthcare is fast and accelerating, and radiology has been anything but exempt. Is your practice among those that are now involved in such discussions—or may be at some point in the not-distant future? If so, consider the following hypothetical.

Your practice has spent a great deal of time in the initial M&A assessment process, either self-guided or with a broker. Now your physician executive leadership, working alongside non-physician practice leadership, have selected a suitable partner. You are on your way.

Thursday, September 13, 2018

Insights Into Appraising Healthcare Service Businesses


Common pitfalls to avoid in healthcare valuation engagements

(from BVR)

Like many industry-specific appraisers, those who focus on valuation in the healthcare industry are often hired to provide initial opinions prior to a transaction. Many times, the valuator may be more knowledgeable about the business than the buyer. The buyer is often waiting for a valuation opinion as well as some initial due diligence. In BVR’s recent webinar, Healthcare Valuation: Approaches to Value and Common Pitfalls, experts Nicholas Janiga and Fred Lara (both of Healthcare Appraisers) covered the most common pitfalls to avoid when working on a healthcare valuation engagement.

Wednesday, August 29, 2018

Q2 Healthcare M&A Unfazed By Feds With No Slowdown In Sight


Despite regulatory uncertainty, healthcare M&A activity remains constant 

(from HealthcareExec)

More than 200 health services deals were reported in the second quarter of 2018, continuing the ongoing streak of mergers and acquisitions in the sector, according to PricewaterhouseCoopers.

Despite regulatory uncertainty in the healthcare environment, mega-deals marched forward during the quarter, which was the 14th consecutive quarter with more than 200 deals.

Year over year, healthcare deals rose 9.4 percent in the second quarter of 2018. Compared to the first quarter of 2018, deals declined 7.3 percent, with 255, according to PwC’s US Health Services Deal Insights Q2 2018 report.

Thursday, July 26, 2018

Does Selling Your Radiology Practice To A Larger Group Make Sense?


Mergers in Radiology: Good or Bad?

(from Diagnostic Imaging)

For the past several years, the conversation around mergers and acquisitions (M&A) and greater consolidation in radiology has focused on whether you should pursue the path. And, if you did, what financial model would be the most financially expedient?

We’ve now reached a point where many in the industry wonder how M&A is working and what impact it’s having on the profession and healthcare. According to many with first-hand experience, partnering to create larger practice models has worked well even if there have been a few obstacles along the way.